Department of Clinical Medicine
Rikke Olesen has not added Biography.
If you are Rikke Olesen and would like to personalize this page please email our Author Liaison for assistance.
Broad-range real time PCR and DNA sequencing for the diagnosis of bacterial meningitis.
Scandinavian journal of infectious diseases , 2006 | Pubmed ID: 16338835
Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans.
Human genetics Jan, 2010 | Pubmed ID: 19771452
Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection.
Journal of reproductive immunology Mar, 2011 | Pubmed ID: 21256601
Interleukin 12B (IL12B) genetic variation and pulmonary tuberculosis: a study of cohorts from The Gambia, Guinea-Bissau, United States and Argentina.
PloS one Feb, 2011 | Pubmed ID: 21339808
Generation of HIV latency in humanized BLT mice.
Journal of virology Jan, 2012 | Pubmed ID: 22013053
Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice.
PLoS pathogens , 2012 | Pubmed ID: 22737068
The histone deacetylase inhibitor panobinostat lowers biomarkers of cardiovascular risk and inflammation in HIV patients.
AIDS (London, England) Jun, 2015 | Pubmed ID: 25870990
Activation of latent human immunodeficiency virus by the histone deacetylase inhibitor panobinostat: a pilot study to assess effects on the central nervous system.
Open forum infectious diseases Jan, 2015 | Pubmed ID: 26034779
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
Journal of virology Oct, 2015 | Pubmed ID: 26223643
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
PLoS pathogens Sep, 2015 | Pubmed ID: 26379282
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.
The lancet. HIV Oct, 2014 | Pubmed ID: 26423811
HIV-1 transcriptional activity during frequent longitudinal sampling in aviremic patients on antiretroviral therapy.
AIDS (London, England) Mar, 2016 | Pubmed ID: 26595541
ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions.
The Journal of clinical investigation Mar, 2016 | Pubmed ID: 26854925
Immune checkpoints and the HIV-1 reservoir: proceed with caution.
Journal of virus eradication Jul, 2016 | Pubmed ID: 27482460
Broad activation of latent HIV-1 in vivo.
Nature communications 09, 2016 | Pubmed ID: 27605062
Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial.
The lancet. HIV 10, 2016 | Pubmed ID: 27658863
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Jun, 2017 | Pubmed ID: 28329286
The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon.
Mucosal immunology Mar, 2018 | Pubmed ID: 28766555
Optimizing recovery of frozen human peripheral blood mononuclear cells for flow cytometry.
PloS one , 2017 | Pubmed ID: 29091947
Treatment of HIV-Infected Individuals with the Histone Deacetylase Inhibitor Panobinostat Results in Increased Numbers of Regulatory T Cells and Limits Lipopolysaccharide-Induced Inflammatory Responses.
mSphere Jan-Feb, 2018 | Pubmed ID: 29468194
cAIMP administration in humanized mice induces a chimerization-level-dependent STING response.
Immunology 06, 2019 | Pubmed ID: 30919991
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals.
AIDS (London, England) 07, 2019 | Pubmed ID: 30932955
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes.
EBioMedicine Jul, 2019 | Pubmed ID: 31300344
Effects of Yoga Asana Practice Approach on Types of Benefits Experienced.
International journal of yoga Sep-Dec, 2019 | Pubmed ID: 31543630
Injury in yoga asana practice: Assessment of the risks.
Journal of bodywork and movement therapies Jul, 2019 | Pubmed ID: 31563359
Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency without T cell activation.
Journal of virus eradication Sep, 2019 | Pubmed ID: 31700655
Fimepinostat, a novel dual inhibitor of HDAC and PI3K, effectively reverses HIV-1 latency without T cell activation.
Journal of virus eradication Sep, 2019 | Pubmed ID: 31700656
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved